ℹ️
🇬🇧
Search
Search for people relevant for "R-CHOP"
R-CHOP
Person
Class
Person
Publication
Programmes
prof. MUDr. Marek Trněný CSc.
Academic staff at First Faculty of Medicine
15 classes
418 publications
Classes
class
Internal Medicine - SE
+1
B00073 |
First Faculty of Medicine
class
Internal Medicine - Hematology
+1
B00307 |
First Faculty of Medicine
class
Review of Internal Diseases 1
B00341 |
First Faculty of Medicine
class
Review of Internal Diseases 2
B00355 |
First Faculty of Medicine
class
Ultrasonographic and Endoscopic Technology
B00816 |
First Faculty of Medicine
class
Internal Medicine Practice before State Examination
+1
B01056 |
First Faculty of Medicine
class
Review of Internal Medicine - Rehabilitation 1
B01536 |
First Faculty of Medicine
class
Diagnosis and therapy in haematology - ethical issues
B02094 |
First Faculty of Medicine
class
Laboratory Methods in Hematology - Diagnostic Tool and Translation´s Research
+1
B02551 |
First Faculty of Medicine
class
News in hematology and blood transfusion
B02697 |
First Faculty of Medicine
Load more classes (5)
Publications
publication
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
2011 |
First Faculty of Medicine
publication
Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era
2010 |
First Faculty of Medicine
publication
Final analysis of the UKLG LY02 trial comparing 6-8 cycles of CHOP with 3 cycles of CHOP followed by a BEAM autograft in patients < 65 years with poor prognosis histologically aggressive NHL.
2010 |
First Faculty of Medicine
publication
Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic
2023 |
First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)
2023 |
First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Characterization of the input material quality for the production of tisagenlecleucel by multiparameter flow cytometry and its relation to the clinical outcome
2023 |
First Faculty of Medicine, Second Faculty of Medicine, Faculty of Science
publication
COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group
2023 |
Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Central Library of Charles University
publication
Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study
2023 |
First Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis
2023 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Sequencing-based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy
2023 |
First Faculty of Medicine, Second Faculty of Medicine
Load more publications (408)
Loading network view...